Delivery Order SPE2DB20D3304-SPE2DB25FW5H8

Award Date 2/6/25
Potential Completion Date 2/7/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,589.52 Firm Fixed Price Delivery Order covers the procurement of 4566901592 - MESALAMINE DR 400 MG CAPSULE 180S, with a period of performance through January 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $18,987.90, is a firm fixed price delivery order for 4557745965 ! MESALAMINE DR 400 MG CAPSULE 180S. The contract does not have a set-aside designation and was awarded on July 8, 2022, with a completion date of July 11,...
This is a $1,554.27 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566833429 MESALAMINE DR 400 MG CAPSULE 180S and has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,528.64 firm fixed-price delivery order contract is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a specialty medication. The contract has a completion date of November 19, 2024 and is not designated as a set-aside award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,573.12 Firm Fixed Price Delivery Order contract is for MESALAMINE 1,000 MG SUPP 30S, with a performance period through February 6, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, valued at $1,179.47, is for the delivery of 4565279776 MESALAMINE DR 400 MG CAPSULE 180S. The contract, which has no set-aside designation, was awarded by the Defense Logistics Agency (DLA) for delivery of these pharmaceutical products by July 29, 2024. Amerisourcebergen, a major supplier of pharmaceutical and medical products to the federal government, holds several Indefinite Delivery Contracts with DLA and other agencies to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,896.72 firm fixed-price delivery order is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,499.79, is for the delivery of 4566307200 MESALAMINE 1,000 MG SUPP 30S. It is a firm fixed-price delivery order contract with a completion date of November 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is a delivery order with a ceiling value of $4,266.70, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of MESALAMINE ER 0.375 GRAM CAP 120S, a pharmaceutical product, with a completion date of September 19, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,276.08, is for the delivery of 180 capsules of Mesalamine delayed-release 400 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and civilian...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB25FW5H8
    Delivery Order

This federal contract award, valued at $1,958.79, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for Firm Fixed Price and covers the supply of MESALAMINE DR 400 MG CAPSULE 180S, a pharmaceutical product. The award has an ultimate completion date of February 7, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/8/25, 9:43 AM